ZA201902720B - Pharmaceutical complex preparation comprising amlodipine, losartan and rosuvastatin - Google Patents

Pharmaceutical complex preparation comprising amlodipine, losartan and rosuvastatin

Info

Publication number
ZA201902720B
ZA201902720B ZA2019/02720A ZA201902720A ZA201902720B ZA 201902720 B ZA201902720 B ZA 201902720B ZA 2019/02720 A ZA2019/02720 A ZA 2019/02720A ZA 201902720 A ZA201902720 A ZA 201902720A ZA 201902720 B ZA201902720 B ZA 201902720B
Authority
ZA
South Africa
Prior art keywords
losartan
rosuvastatin
amlodipine
complex preparation
pharmaceutical complex
Prior art date
Application number
ZA2019/02720A
Inventor
Jun Cho Hyuk
Ee Lim Sol
Taek Im Ho
Il Kim Yong
Hyun Park Jae
Soo Woo Jong
Original Assignee
Hanmi Pharm Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62146632&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201902720(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hanmi Pharm Ind Co Ltd filed Critical Hanmi Pharm Ind Co Ltd
Publication of ZA201902720B publication Critical patent/ZA201902720B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2019/02720A 2016-11-15 2019-04-30 Pharmaceutical complex preparation comprising amlodipine, losartan and rosuvastatin ZA201902720B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020160152077 2016-11-15
PCT/KR2017/012703 WO2018093096A2 (en) 2016-11-15 2017-11-10 Pharmaceutical complex preparation comprising amlodipine, losartan and rosuvastatin

Publications (1)

Publication Number Publication Date
ZA201902720B true ZA201902720B (en) 2020-08-26

Family

ID=62146632

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/02720A ZA201902720B (en) 2016-11-15 2019-04-30 Pharmaceutical complex preparation comprising amlodipine, losartan and rosuvastatin

Country Status (11)

Country Link
CO (1) CO2019004796A2 (en)
CR (1) CR20190265A (en)
DO (1) DOP2019000092A (en)
EA (1) EA201991190A1 (en)
EC (1) ECSP19040732A (en)
MX (1) MX2019005230A (en)
NI (1) NI201900048A (en)
PH (1) PH12019500779A1 (en)
SG (1) SG11201903132YA (en)
WO (1) WO2018093096A2 (en)
ZA (1) ZA201902720B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2007385A4 (en) * 2006-03-23 2010-08-18 Sinai School Medicine Cardiovascular composition and use the same for the treatment of alzheimers disease
KR101298788B1 (en) * 2011-03-15 2013-08-22 보령제약 주식회사 A combined formulation with improved stability
MX358211B (en) * 2012-07-23 2018-08-10 Landsteiner Scient S A De C V New differential-release pharmaceutical composition containing three active principles.
KR101910901B1 (en) * 2013-11-29 2018-10-24 한미약품 주식회사 Pharmaceutical complex formulation comprising amlodipine, losartan and rosuvastatin
KR102369607B1 (en) * 2014-09-30 2022-03-03 한미약품 주식회사 Solid Pharmaceutical Composition Comprising Amlodipine and Losartan

Also Published As

Publication number Publication date
WO2018093096A2 (en) 2018-05-24
WO2018093096A3 (en) 2018-07-26
SG11201903132YA (en) 2019-05-30
CR20190265A (en) 2019-08-22
EA201991190A1 (en) 2019-10-31
PH12019500779A1 (en) 2019-07-29
MX2019005230A (en) 2019-08-14
NI201900048A (en) 2019-10-11
ECSP19040732A (en) 2019-07-31
CO2019004796A2 (en) 2019-05-21
DOP2019000092A (en) 2019-09-30

Similar Documents

Publication Publication Date Title
IL252346A0 (en) Heteroaryl compounds, their preparation and use
IL276695B (en) Antibodies, pharmaceutical compositions and uses thereof
EP3505519A4 (en) Pyridinamine-substituted heterotricyclo compounds, preparation thereof, and use in medicines
HK1255566A1 (en) Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof
ZA201603272B (en) Pharmaceutical combination formulation comprising amlodipine, losartan and rosuvastatin
HK1256752A1 (en) Substituted benzimidazoles, their preparation and their use as pharmaceuticals
ZA201902718B (en) Pharmaceutical complex formulation comprising amlodipine, losartan and chlorthalidone
PL3223796T3 (en) Pharmaceutical compositions, preparation and uses thereof
IL252397A0 (en) Pharmaceutical composition, preparation and uses thereof
IL261643B (en) Piperidine derivatives, their preparation and use
HUE055181T2 (en) Pharmaceutical composition containing amlodipine, valsartan, and rosuvastatin
IL290114A (en) Pharmaceutical composition, preparation and uses thereof
LT3229843T (en) Pharmaceutical composition, preparation and uses thereof
ZA201703015B (en) Solid pharmaceutical composition comprising amlodipine and losartan
PT3288575T (en) Bioassimilable protein-melanin complex, preparation and uses
IL262597B (en) Piperidinyl derivatives, their preparation and use
ZA201902720B (en) Pharmaceutical complex preparation comprising amlodipine, losartan and rosuvastatin
HRP20182167T1 (en) Benzylhydroxyde derivatives, preparation thereof and therapeutic use thereof
TH1601003068A (en) Pharmaceutical combination formulation comprising amlodipine, losartan, and rosuvastatin.